Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition in the precuneus

PLoS One. 2015 Mar 23;10(3):e0121356. doi: 10.1371/journal.pone.0121356. eCollection 2015.

Abstract

Amyloid deposition, a crucial event of Alzheimer's disease (AD), emerges in distinct brain regions. A key question is what triggers the assembly of the monomeric amyloid ß-protein (Aß) into fibrils in the regions. On the basis of our previous findings that gangliosides facilitate the initiation of Aß assembly at presynaptic neuritic terminals, we investigated how lipids, including gangliosides, cholesterol and sphingomyelin, extracted from synaptic plasma membranes (SPMs) isolated from autopsy brains were involved in the Aß assembly. We focused on two regions of the cerebral cortex; precuneus and calcarine cortex, one of the most vulnerable and one of the most resistant regions to amyloid deposition, respectively. Here, we show that lipids extracted from SPMs isolated from the amyloid-bearing precuneus, but neither the amyloid-free precuneus nor the calcarine cortex, markedly accelerate the Aß assembly in vitro. Through liquid chromatography-mass spectrometry of the lipids, we identified an increase in the ratio of the level of GD1b-ganglioside containing C20:0 fatty acid to that containing C18:0 as a cause of the enhanced Aß assembly in the precuneus. Our results suggest that the local glycolipid environment play a critical role in the initiation of Alzheimer amyloid deposition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Amyloid beta-Peptides / metabolism*
  • Cholesterol / metabolism
  • Fatty Acids / metabolism*
  • Female
  • Gangliosides / metabolism*
  • Humans
  • Male
  • Parietal Lobe / metabolism*
  • Presynaptic Terminals / metabolism
  • Sphingomyelins / metabolism
  • Synaptic Membranes / metabolism

Substances

  • Amyloid beta-Peptides
  • Fatty Acids
  • Gangliosides
  • Sphingomyelins
  • ganglioside, GD1b
  • Cholesterol

Grants and funding

This study was supported by the Research Funding of the Longevity Sciences (25-19) from the National Center for Geriatrics and Gerontology and the Strategic Research Program for Brain Sciences by the Ministry of Education, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.